MKI67 and neoplasm: Immunofluorescence assessment of CWR-R1ca primary tumor sections proved OC-PF effectively suppressed the tumor cells’ proliferation marker ki67 and the endothelial vasculogenesis marker CD31 compared to the placebo control-treated group.